z-logo
open-access-imgOpen Access
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
Author(s) -
Joseph G. Rogers,
Francis D. Pagani,
Antone Tatooles,
Geetha Bhat,
Mark S. Slaughter,
Emma J. Birks,
Steven W. Boyce,
Samer S. Najjar,
Valluvan Jeevanandam,
Allen S. Anderson,
Igor D. Gregorič,
Hari R. Mallidi,
Katrin Leadley,
Keith D. Aaronson,
O.H. Frazier,
Carmelo A. Milano
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1602954
Subject(s) - medicine , ventricular assist device , destination therapy , heart failure , clinical endpoint , randomized controlled trial , heart transplantation , investigational device exemption , confidence interval , population , ejection fraction , stroke (engine) , surgery , cardiology , relative risk , clinical trial , mechanical engineering , environmental health , engineering
Mechanical circulatory support with a left ventricular assist device (LVAD) is an established treatment for patients with advanced heart failure. We compared a newer LVAD design (a small intrapericardial centrifugal-flow device) against existing technology (a commercially available axial-flow device) in patients with advanced heart failure who were ineligible for heart transplantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom